Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Eva Myriokefalitaki is a leading gynaecological oncologist whose research focuses on surgical outcomes in cervical cancer, particularly comparing minimally invasive and open surgical approaches. Her most cited work, the 2019 study "Survival of women with early‐stage cervical cancer in the UK treated with minimal access and open surgery" (24 citations), critically examines the controversial findings from landmark New England Journal of Medicine publications that suggested worse outcomes for women undergoing radical hysterectomy via minimal access routes. Dr. Myriokefalitaki’s contribution provides essential UK-specific data, helping to contextualize these alarming international results and informing clinical decision-making. Her research has significant implications for surgical practice, directly impacting patient counseling and treatment protocols. By analyzing real-world outcomes, she has advanced the understanding of how surgical approach affects survival in early-stage cervical cancer, making her work vital for both clinicians and researchers navigating this complex debate. Her studies underscore the importance of evidence-based surgical selection in gynaecological oncology.